ThermoGenesis Holdings Announces That ImmuneCyte Joint Venture Receives $3.0 Million Equity Investment – P&T Community

RANCHO CORDOVA, Calif., Jan. 3, 2020 /PRNewswire/ --ThermoGenesis Holdings, Inc.(Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that ImmuneCyte Life Sciences, Inc. ("ImmuneCyte"), an 80/20 joint venture between HealthBanks Biotech (USA) and ThermoGenesis, has closed a $3.0 million equity investment with a private institution

Read more
Vor Biopharma Expands Leadership Team with Chief Legal Officer and Vice President of People – Global Banking And Finance Review

Vor Biopharma, an oncology company pioneering engineered hematopoietic stem cells (eHSCs) for the treatment of cancer, today announced two additions to its leadership. Seasoned patent attorney Amy Mendel joins Vor as Chief Legal Officer and human resources executive Tania Philipp joins as Vice President of People. These experienced life sciences specialists continue to round out Vors management team as the company expands, develops its platform technology, and advances its pipeline of eHSC-based therapies.

Read more
Stem Cells Doctors | Regenerative Medicine | Stem Cell …

Regenerative medicine, the most recent and emerging branch of medical science, deals with functional restoration of tissues or organs for the patient suffering from severe injuries or chronic diseaseconditions, in the state where bodies own regenerative responses do not suffice The spectacular progress in the field of stem cell research has laid the foundation for cell based therapies of disease which cannot be cured by conventional medicines. The indefinite self-renewal and potential to differentiate into other types of cells represent stem cells as frontiers of regenerative medicine

Read more